Toggle menu
  • Login or Sign Up
  • 0
    • USD
      • British Pound
      • US Dollar
  • Biopharma Research
    Reset Search ×
    • 0
    Reset Search ×
    • USD
      • British Pound
      • US Dollar

      Main Menu

    • OUR SERVICES
      • Custom Research Services
      • Laboratory End User Surveys
    • ABOUT US
    • CONTACT US
    • Shop By Category

    • All Diagnostics Markets
    • PARTNERING, LICENSING, M&A
    • Multiplex Diagnostics
    • Therapeutics
    • Genomics
    • Cancer Diagnostics
    • Infectious Disease Diagnostics
    • COVID-19 Diagnostics
    • Point of Care (POC) Diagnostics
    • Direct-to-Consumer (DTC) Diagnostics
    • Rapid Diagnostics
    • Laboratory Techniques
    • Medical Laboratory Services
    • Calibration
    • USD
      • British Pound
      • US Dollar
    • Gift Certificates
    • Login or Sign Up

    Market ReportsMarket Reports

    Shop by Category

  • All Diagnostics Markets
  • PARTNERING, LICENSING, M&A
  • Multiplex Diagnostics
  • Therapeutics
  • Genomics
  • Cancer Diagnostics
  • Infectious Disease Diagnostics
  • COVID-19 Diagnostics
  • Point of Care (POC) Diagnostics
  • Direct-to-Consumer (DTC) Diagnostics
  • Rapid Diagnostics
  • Laboratory Techniques
  • Medical Laboratory Services
  • Calibration

    • Main Menu

    • OUR SERVICES
      • Custom Research Services
      • Laboratory End User Surveys
    • ABOUT US
    • CONTACT US
    • Shop By Category

    • All Diagnostics Markets
    • PARTNERING, LICENSING, M&A
    • Multiplex Diagnostics
    • Therapeutics
    • Genomics
    • Cancer Diagnostics
    • Infectious Disease Diagnostics
    • COVID-19 Diagnostics
    • Point of Care (POC) Diagnostics
    • Direct-to-Consumer (DTC) Diagnostics
    • Rapid Diagnostics
    • Laboratory Techniques
    • Medical Laboratory Services
    • Calibration
    Reset Search ×
    • 0
    • Home
    • Infectious Disease Diagnostics
    • Molecular Diagnostics at the Point of Care by Application, Technology, Place, Product and Country with Executive Guides 2023 to 2027
  • Molecular Diagnostics Markets at the Point of Care 2023 to 2027
  • Molecular Diagnostics Markets at the Point of Care 2023 to 2027

    Molecular Diagnostics at the Point of Care by Application, Technology, Place, Product and Country with Executive Guides 2023 to 2027

    $6,995.00
    (You save )
    Write a Review

    SKU:
    HSR-127-S
    Condition:
    New

    Adding to cart… category.add_cart_announcement

    Share This Article

    • Overview

    Product Description

    Molecular Diagnostics at the Point of Care by Application, Technology, Place, Product and Country with Executive Guides 2023 to 2027

     

    Publication date: June 13, 2023

    Page count: 572

    Table of Contents

    Can a rapidly growing market expand even faster?  Find out all about it in this comprehensive report on Molecular Diagnostics at the Point of Care.

    • Are targeted tests for specific pathogens going to be obsolete?
    • Will diagnostics replace physicians?

     

    Point of Care testing is proving itself in the market. Players are reporting double digit growth. Lowering costs, improving outcomes and even helping in the battle against Antimicrobial Resistance (AMR).  Learn about this market including the issues and outlooks.  The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success.  It could possibly displace most frontline test protocols AND save money at the same time.

    Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. 

    Make projections with confidence using the latest data.

    If a country forecast is not already listed, purchasers can request individual country market size information, or other customization, without additional charge with the corporate license.

    All report data is available in Excel format on request with the corporate license.
     

    ABOUT THE LEAD AUTHOR

    Mr. Greg Powell, B.SC., M.B.A is an experienced business and clinical professional.  He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping."  He has worked in laboratory testing and management for over 20 years.  Mr. Powell’s education includes:

    • B.Sc. (Chemistry) University of BC
    • M.B.A. (Finance and Policy) University of BC
    • Market Research Seminar - Burke Institute
    • Finance for Senior Executives - Harvard Business School

    Product Videos

    Custom Field

    Product Reviews

    Write a Review

    Write a Review

    ×
    Molecular Diagnostics Markets at the Point of Care 2023 to 2027
    Molecular Diagnostics at the Point of Care by Application, Technology, Place, Product and Country with Executive Guides 2023 to 2027
    ×
    • Recommended
    Computed Tomography (CT) Markets 2023 to 2027
    Quick view

    COMPUTED TOMOGRAPHY (CT) MARKETS BY APPLICATION, TECHNOLOGY, PLACE AND PRODUCT WITH EXECUTIVE AND CONSULTANT GUIDES 2023 - 2027

    $6,995.00 - $13,995.00
    Choose Options
    Proteomic Biomarker Analytics Market 2023 to 2027
    Quick view

    Proteomic Biomarker Analytics Markets: Forecasts by Application, Technology, Product and Place with Executive and Consultant Guides 2023 to 2027

    $6,995.00 - $13,995.00
    Choose Options
    Cancer Molecular Diagnostics Markets 2023 to 2027
    Quick view

    Cancer Molecular Diagnostics: Strategies and Trends, Market Forecasts by Cancer Type, Product and Place with Executive and Consultant Guides 2023 to 2027

    $6,995.00 - $13,995.00
    Choose Options
    Home Diagnostics Markets 2023 to 2027
    Quick view

    HOME DIAGNOSTICS MARKETS: Strategies and Trends, Forecasts by Application, Channel, Technology and Country with Market Analysis and Executive Guides 2023 to 2027

    $6,995.00 - $13,995.00
    Choose Options
    Immunoassay Markets 2023 to 2027
    Quick view

    Immunoassay Markets: Strategies and Trends, Forecasts by Application, Technology, Product, User and Country with Executive and Consultant Guides 2023 to 2027

    $6,995.00 - $13,995.00
    Choose Options
    • Recommended
    • Computed Tomography (CT) Markets 2023 to 2027
      Quick view

      COMPUTED TOMOGRAPHY (CT) MARKETS BY APPLICATION, TECHNOLOGY, PLACE AND PRODUCT WITH EXECUTIVE AND CONSULTANT GUIDES 2023 - 2027

      $6,995.00 - $13,995.00
      Choose Options
    • Proteomic Biomarker Analytics Market 2023 to 2027
      Quick view

      Proteomic Biomarker Analytics Markets: Forecasts by Application, Technology, Product and Place with Executive and Consultant Guides 2023 to 2027

      $6,995.00 - $13,995.00
      Choose Options
    • Cancer Molecular Diagnostics Markets 2023 to 2027
      Quick view

      Cancer Molecular Diagnostics: Strategies and Trends, Market Forecasts by Cancer Type, Product and Place with Executive and Consultant Guides 2023 to 2027

      $6,995.00 - $13,995.00
      Choose Options
    • Home Diagnostics Markets 2023 to 2027
      Quick view

      HOME DIAGNOSTICS MARKETS: Strategies and Trends, Forecasts by Application, Channel, Technology and Country with Market Analysis and Executive Guides 2023 to 2027

      $6,995.00 - $13,995.00
      Choose Options
    • Immunoassay Markets 2023 to 2027
      Quick view

      Immunoassay Markets: Strategies and Trends, Forecasts by Application, Technology, Product, User and Country with Executive and Consultant Guides 2023 to 2027

      $6,995.00 - $13,995.00
      Choose Options
    ×
    Contact Us
    Westfield House
    Millfield Lane
    Nether Poppleton
    YORK, YO26 6GA
    United Kingdom
    +44(0)1904 868857
    Accounts & Orders
    • Login or Sign Up
    • Order Status
    • Privacy Security Shipping
    Navigate
    • OUR SERVICES
    • ABOUT US
    • CONTACT US
    Join Our Mailing List

    Sign up for our newsletter to receive specials and up to date product news and releases.

    • © Biopharma Research Ltd